about
Pregnancy in HIV clinical trials in Sub Saharan Africa: failure of consent or contraception?Co-administration of fluconazole increases nevirapine concentrations in HIV-infected Ugandans.Treatment decisions and mortality in HIV-positive presumptive smear-negative TB in the Xpert™ MTB/RIF era: a cohort study.Coreceptor and cytokine concentrations may not explain differences in disease progression observed in HIV-1 clade A and D infected Ugandans.The future of financing for HIV services in Uganda and the wider sub-Saharan Africa region: should we ask patients to contribute to the cost of their care?Prevalence and type of drug-drug interactions involving ART in patients attending a specialist HIV outpatient clinic in Kampala, Uganda.Primary prophylaxis of cryptococcal disease with fluconazole in HIV-positive Ugandan adults: a double-blind, randomised, placebo-controlled trial.Possible misdiagnosis of HIV associated lymphoma as tuberculosis among patients attending Uganda Cancer Institute.Cryptococcal disease and the burden of other fungal diseases in Uganda; Where are the knowledge gaps and how can we fill them?Exploring attitudes and perceptions of patients and staff towards an after-hours co-pay clinic supplementing free HIV services in Kampala, UgandaMonitoring Antiretroviral Therapy in Uganda: Budget Impact Analysis of Two Strategies for Viral Load Monitoring Versus Immunologic Monitoring.Characteristics of Sexually Transmitted Infections among High-Risk HIV-Positive Patients Attending an Urban Clinic in Uganda.Barriers to starting ART and how they can be overcome: individual and operational factors associated with early and late start of treatment.Use of nail and oral pigmentation to determine ART eligibility among HIV-infected Ugandan adults.Symptom burden in HIV-infected adults at time of HIV diagnosis in rural Uganda.Strengthening the "Viral Failure Pathway": Clinical Decision and Outcomes of Patients With Confirmed Viral Failure in a Large HIV Care Clinic in Uganda.Elevated Aspergillus-specific antibody levels among HIV infected Ugandans with pulmonary tuberculosis.Point-of-care diagnostics: needs of African health care workers and their role combating global antimicrobial resistance
P50
Q31139344-6843083E-9D0C-4825-ABCE-75EB03A87DB4Q33602047-4FDADC7A-A8F5-4E54-8419-0671B56FDB0DQ33808388-E0BF28A6-AFA5-4916-A0CD-400E563A24F0Q33927434-37AD78ED-A734-4CD6-B716-D415A2EBC65CQ36115130-D0ACFAA2-733E-4EBD-A509-94C3B3C49E94Q36298965-2FFDDF9A-F887-4B2F-A2A9-0B0B19997350Q36870447-DEE6E847-4560-4DCE-959D-B8EDC05E637FQ37700895-93387BD3-FD5C-4443-B3EC-4CA5069B9AC6Q38602639-74CC15CB-6EE5-4394-9A6C-D55A2BBE9190Q38613734-E2101D5E-E29C-45DE-A89B-5BCB53BAD65CQ38861011-3CEACBC7-421D-4C03-8957-D8155A2B0A58Q38864300-81A82776-AF88-4D44-B0A0-3D23A1572AACQ38871625-06719B3C-CB9A-4B6C-88B4-BC37397E1211Q38872635-B2AAB0A4-D94A-42EC-A2BA-45CF44E8DD98Q38872706-08B6A3B4-1769-430E-9631-0CDE41E962E2Q46330504-FD3B50C4-711E-4D79-9831-E0E20DA6C6CCQ47102823-A44C0C5C-8D49-425D-80B3-63EB2DB8228EQ90967828-342420F2-B570-499A-AA29-2C2716396997
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Rosalind Parkes-Ratanshi
@ast
Rosalind Parkes-Ratanshi
@en
Rosalind Parkes-Ratanshi
@es
Rosalind Parkes-Ratanshi
@nl
type
label
Rosalind Parkes-Ratanshi
@ast
Rosalind Parkes-Ratanshi
@en
Rosalind Parkes-Ratanshi
@es
Rosalind Parkes-Ratanshi
@nl
prefLabel
Rosalind Parkes-Ratanshi
@ast
Rosalind Parkes-Ratanshi
@en
Rosalind Parkes-Ratanshi
@es
Rosalind Parkes-Ratanshi
@nl
P106
P31
P496
0000-0001-9297-1311